Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the Written Answer by Lord Markham on 7 March 2023 (HL5695), to which body the recommendations on the relevant cohorts for COVID-19 therapeutics are to be made, as discussed by the Chair of the Therapeutics Clinical Review Panel on 2 February; and whether the preparation of these recommendations included reviewing details within the report Qcovid 4 - Predicting risk of death or hospitalisation from COVID-19, published in August 2022.

The Therapeutics Clinical Review Panel met on 31 January 2023 to review most recent evidence on COVID-19 risk, including the National Institute for Health and Care Research rapid study on those who remain vulnerable to poor outcomes from COVID-19 despite vaccination. Advice is then provided to the four United Kingdom Chief Medical Officers. The evidence considered by the Panel was also shared with the National Institute for Clinical Excellence.